1
Clinical Trials associated with HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute)A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor
To evaluate the safety and effectiveness of cell therapy using herinCAR-PD1 cells to treat advanced cancer.
Individuals greater than or equal to 18 years of age and less than or equal to 70 years of age who have been diagnosed with relapsed or refractory cancer that has not responded to or has relapsed after standard treatment.
100 Clinical Results associated with HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute)
100 Translational Medicine associated with HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute)
100 Patents (Medical) associated with HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute)
100 Deals associated with HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute)